Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$882M |
| 2 |
Netflix
NFLX
|
+$813M |
| 3 |
T-Mobile US
TMUS
|
+$722M |
| 4 |
Intuitive Surgical
ISRG
|
+$301M |
| 5 |
DexCom
DXCM
|
+$246M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$2.03B |
| 2 |
Salesforce
CRM
|
+$890M |
| 3 |
CrowdStrike
CRWD
|
+$654M |
| 4 |
Apple
AAPL
|
+$542M |
| 5 |
Atlassian
TEAM
|
+$353M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.75% |
| 2 | Healthcare | 20.44% |
| 3 | Consumer Discretionary | 17.04% |
| 4 | Financials | 10.94% |
| 5 | Communication Services | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Molina Healthcare
MOH
$10.2B
| $86.5M | 0.09% |
261,939
-28,745
| -10% | -$9.76M |
|
127
Amgen
AMGN
$208B
| $85.5M | 0.09% |
325,658
+154,786
| +91% | +$41.5M |
|
|
SUM
128
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $84.8M | 0.09% |
2,986,930
-320
| -0% | -$8.82K |
|
129
Fortive
FTV
$17.9B
| $84.7M | 0.09% |
1,750,159
+93,610
| +6% | +$4.53M |
|
130
Mondelez International
MDLZ
$79.5B
| $84.6M | 0.09% |
1,269,617
-22,463
| -2% | -$1.42M |
|
131
Workday
WDAY
$39.6B
| $83.8M | 0.09% |
501,056
-3,676
| -0.7% | -$573K |
|
132
Tower Semiconductor
TSEM
$24.8B
| $82.4M | 0.08% |
1,907,094
+1,350
| +0.1% | +$58.7K |
|
133
Crown Holdings
CCK
$12.8B
| $82M | 0.08% |
996,923
-1,080,826
| -52% | -$86.1M |
|
134
Patterson-UTI
PTEN
$3.98B
| $79.7M | 0.08% |
4,730,244
-16,005
| -0.3% | -$264K |
|
135
Acadia Healthcare
ACHC
$2.76B
| $79.6M | 0.08% |
966,448
-227,451
| -19% | -$18.8M |
|
136
Progyny
PGNY
$2.44B
| $78.8M | 0.08% |
2,530,967
+725,232
| +40% | +$26.2M |
|
137
Xcel Energy
XEL
$48.8B
| $76.3M | 0.08% |
1,088,696
-467,748
| -30% | -$31.1M |
|
138
Eversource Energy
ES
$26.9B
| $75.3M | 0.08% |
898,025
-130,029
| -13% | -$10.3M |
|
139
GFL Environmental
GFL
$14.9B
| $75.2M | 0.08% |
2,572,746
-507,294
| -16% | -$13.8M |
|
140
Jazz Pharmaceuticals
JAZZ
$15.9B
| $73.6M | 0.07% |
462,113
+16,352
| +4% | +$2.4M |
|
141
General Motors
GM
$80.4B
| $72.9M | 0.07% |
2,167,682
+348,737
| +19% | +$12.9M |
|
142
Edison International
EIX
$28.2B
| $72.8M | 0.07% |
1,144,618
-107,306
| -9% | -$6.59M |
|
143
Cooper Companies
COO
$14.1B
| $72.6M | 0.07% |
878,160
+190,960
| +28% | +$14.1M |
|
144
FirstEnergy
FE
$28B
| $72.1M | 0.07% |
1,718,349
+783,017
| +84% | +$30.6M |
|
145
Kontoor Brands
KTB
$4.63B
| $71.6M | 0.07% |
1,791,022
+247
| +0% | +$9.63K |
|
146
Sprout Social
SPT
$516M
| $70.1M | 0.07% |
1,241,044
-21,179
| -2% | -$1.24M |
|
147
SLM Corp
SLM
$4.89B
| $69.8M | 0.07% |
4,203,938
-714,846
| -15% | -$11.7M |
|
148
Pinnacle Financial Partners Inc
PNFP
$15.9B
| $69.4M | 0.07% |
945,819
-51,757
| -5% | -$4.16M |
|
149
Celldex Therapeutics
CLDX
$2.99B
| $69.3M | 0.07% |
1,555,318
+281,297
| +22% | +$10M |
|
150
KBR
KBR
$4.62B
| $69M | 0.07% |
1,307,498
-135,027
| -9% | -$6.72M |
|
Similar funds
Jennison Associates's Q4 2022 Portfolio in Review
As of Q4 2022, Jennison Associates held 646 positions worth $98.7B, down 1.9% from $101B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Jennison Associates withdrew a net $3.42B in Q4 2022, closing 75 positions and reducing 267 holdings. Its most notable exit was Target, an estimated $231M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jennison Associates opened a new position in ICICI Bank worth $102M.
- Jennison Associates's largest Q4 2022 buy was ICICI Bank: 4,644,701 shares worth $102M.
- Jennison Associates added most to NVIDIA in Q4 2022, an estimated $882M increase.
- Jennison Associates's biggest Q4 2022 reduction was Tesla, cutting an estimated $2.03B.
- Jennison Associates fully exited Target in Q4 2022, selling an estimated $231M.
- Jennison Associates's ten largest holdings make up 35% of its $98.7B portfolio in Q4 2022.
- Jennison Associates opened 47 new positions and closed 75 in Q4 2022.
- Jennison Associates's portfolio value fell 1.9% quarter-over-quarter to $98.7B.
Based on Jennison Associates's 13F filing for Q4 2022, filed 9 Feb 2023.